Success Metrics

Clinical Success Rate

100.0%

Based on 5 completed trials

Completion Rate

100%(5/5)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

43%

Ph phase_2

29%

Ph phase_3

14%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 2Efficacy & side effects

2(33.3%)

Phase 3Large-scale testing

1(16.7%)

N/ANon-phased studies

3(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(5)

Other(2)

Detailed Status

Completed5

unknown2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 22 (33.3%)

Phase 31 (16.7%)

N/A3 (50.0%)

Trials by Status

unknown229%

completed571%

Recent Activity

0 active trials

Showing 5 of 7

completedphase_3

Clinical Trials (7)

Showing 7 of 7 trials

NCT00000248Phase 3

Dose Response Trial of Pergolide for Cocaine Dependence - 1

Completed

NCT00000269Phase 2

Pergolide Treatment for Substance Abusers - 4

Completed

NCT00000215Phase 2

IV Cocaine Abuse: A Laboratory Model - 4

Completed

NCT00004433Not Applicable

Randomized Study of Pergolide in Children With Tourette Syndrome

Completed

NCT00624741

Compassionate Use Study of Pergolide in Patients With Parkinson's Disease

Unknown

NCT01066403Not Applicable

Adjuvant Therapy With Pergolide in Treating Cognitive Deficits in Schizophrenia

Completed

NCT00252044Not Applicable

Pergolide for Cognitive Symptoms in Schizotypal Personality Disorder

Unknown

All 7 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 7